CHM 5.00% 1.9¢ chimeric therapeutics limited

Ann: CHM CORE-NK vactosertib Phase 1b study re-opens enrolment, page-16

  1. 12,382 Posts.
    lightbulb Created with Sketch. 3783
    The difference between the others and Hopper is that they talk positively about their assets and clearly demonstrate the value and the likelihood of making a good investment return. Hopper on the other side stands for value destruction and offering potential investors a capital loss. I wonder how long he continues to be convinced that his way is superior and attractive to investors. JC and LC did their best to drive the GMB data forwards and to secure Azer-Cel for IMU. What did he do? Instead of demanding a justified premium he offered a 30% and higher discount. The CEOs added value which Hopper sold as crap.

    And Monday's useless and insane anns is the next product of his brain. Maybe something isn't right in his head.

    GLTA
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
-0.001(5.00%)
Mkt cap ! $16.64M
Open High Low Value Volume
2.2¢ 2.2¢ 1.9¢ $31.47K 1.541M

Buyers (Bids)

No. Vol. Price($)
5 1200682 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 12227 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.